誉衡药业最新股东户数环比下降7.96% 筹码趋向集中

Group 1 - The core point of the article is that Yuheng Pharmaceutical has seen a decrease in the number of shareholders and fluctuations in its stock price, alongside mixed financial performance in the first quarter [2] Group 2 - As of August 10, the number of shareholders for Yuheng Pharmaceutical was 121,400, a decrease of 10,500 from the previous period, representing a decline of 7.96% [2] - The closing price of Yuheng Pharmaceutical on the reporting date was 3.73 yuan, down 0.80%, with a cumulative increase of 0.54% since the concentration of shares began [2] - The stock experienced 4 days of price increases and 7 days of declines during the reporting period [2] Group 3 - The latest margin trading data as of August 15 shows a total margin balance of 563 million yuan, with a financing balance of 563 million yuan, indicating an increase of 131 million yuan, or 30.31%, since the concentration of shares began [2] Group 4 - In the first quarter, Yuheng Pharmaceutical reported total revenue of 551 million yuan, a year-on-year decrease of 7.06%, while net profit was 60.25 million yuan, a year-on-year increase of 15.24% [2] - The basic earnings per share were 0.0274 yuan, and the weighted average return on net assets was 3.08% [2]